About this trial
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation.
Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes.
This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function.
The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.
Eligibility criteria
Qualifiers
Has kidney failure and is on the waitlist for a kidney transplant
Age 16 years and over
Able to give informed consent
Disqualifiers
Contraindication to CT scanning, including contrast allergy
Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation
Inability to give informed consent
Trial design
Treatments tested in this trial
- Computed tomography coronary angiography (CTCA)
Treatment groups
Sponsors and collaborators
University of Edinburgh
Lead sponsor
Chief Scientist Office of the Scottish Government
Collaborator
University of Glasgow
Collaborator
NHS Lothian
Collaborator
NHS Greater Glasgow and Clyde
Collaborator